Shasun Pharmaceuticals was locked in 20% upper circuit at Rs 77.90 after reporting a consolidated net profit of Rs 24.6 crore for the third quarter ended December, against a loss of Rs 9.65 crore in the corresponding quarter last year.
Net sales rose 55% to Rs 302 crore on year-on-year basis.
The trading volumes on the counter surged multiple fold; with a combined 4.72 million shares having changed hands so far, against an average around 106,000 shares that were traded daily in past two weeks on the NSE and BSE.
There are pending buy orders for around 44,000 shares on both the exchanges.
